Correlation between pathologic complete response, event-free survival/disease-free survival and overall survival in neoadjuvant and/or adjuvant HR+/HER2-breast cancer.
Frontiers in oncology（2023）
摘要
EFS/DFS were moderately correlated with OS in this trial-level analysis. They may be considered as valid surrogates for OS in HR+/HER2- breast cancer.
更多查看译文
关键词
HR,HER2-breast cancer,neoadjuvant,adjuvant,overall survival,surrogate endpoints,surrogate threshold effect
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要